Dr. Noëlle-Ann Sunstrom, Chief Executive Officer
PhD, MBA, FAICD


Dr Sunstrum has over 15 years experience in the biopharmaceutical industry including more than 10 years of senior management and Board experience. Dr Sunstrom has worked with large global pharmaceutical companies throughout her professional career.  This extensive industry expertise has given Dr Sunstrom a thorough understanding of business development, intellectual property, project management, budgets and timelines in the biopharmaceutical industry. 

 

Dr Sunstrom’s Publications:

R.J. Sleiman, P.P. Gray, M.N. McCall, and N.A. Sunstrom. 2007.  Accelerated Cell Line Development using Fluorescence Activated Cell Sorting to Select for High Antibody Producing Clones. Biotechnology and Bioengineering Vol 99, Issue 3, 15 February 2008, Pages: 578-587


M.W. Liao and N.A. Sunstrom. 2006.  A transient expression vector for recombinant protein production in CHO cells. Journal of Chemical Technology and Biotechnology 81: 82-88


R.K. Kunaparaju, M.W. Liao and N.A. Sunstrom. 2005.  Epi-CHO, an episomal expression system for recombinant protein production in CHO cells.  Biotechnology and Bioengineering. 91 (6):670-677.


L. de Boer, P.P. Gray and N.A. Sunstrom. 2004.  Enhanced productivity of G1 phase Chinese hamster ovary cells using the GADD 153 promoter. Biotechnology Letters 26 (1):  61-65.


C. Bailey, S. Tait and N.A. Sunstrom. 2002. High-throughput clonal selection of recombinant CHO cells using a dominant selectable and amplifiable metallothionein-GFP fusion protein.  Biotechnology and Bioengineering 80: 670-676.
N.A. Sunstrom, R. Gay, D. Wong, N Kitchen, L. DeBoer and P. Gray. 2000. Insulin-like Growth Factor-I Mediates Growth and Survival of Chinese Hamster Ovary Cells.  Biotechnology Progress 16 (5): 698-702.

 

N.A. Sunstrom, Sugiyono, S. Hunt, C. Bailey, M. Baig, M. Sleigh and P. Gray. 2000. Regulated Autocrine Growth of CHO Cells.  Cytotechnology 34(1): 39-46.


N.A. Sunstrom, M. Baig, L. Cheng, Sugiyono and P. Gray. 1999. Current Applications of Cell Culture Engineering – Vol 3. Recombinant IGF-I production in Super-CHO results in the expression of IGF-I receptor and IGF binding protein 3.)  Cell culture Engineering VI Edited by M.J. Betenbaugh, J.J. Chalmers, B. Arathoon and A.J. Mastrangelo.  Kluwer Academic Publishers ISBN 0-7923-5575-X pg 91-99.


C. Bailey, M. Baig, P. Gray and N.A. Sunstrom. 1999. A Rapid Selection/amplification Procedure for High-level Expression of Recombinant Protein in a Metal-amplifiable Mammalian Expression System. Biotechnology Techniques 13(9): 615-619.
N.A. Sunstrom, M. Baig, L. Cheng, D. Payet, Sugyiono and P. Gray. 1998. Recombinant Insulin-like Growth Factor-I (IGF-I) Production in Super-CHO Results in the Expression of IGF-I Receptor and IGF Binding Protein 3. Cytotechnology 28: 91-99.
N.A. Sunstrom, L.S. Premkumar, A. Premkumar, G.Ewart, G.B. Cox, and P.W. Gage. 1996.  Ion channels formed by NB, and influenza B virus protein. J. Memb. Biol.150: 127-132.


P.W. Gage, N.A.Sunstrom, , L.S.Premkumar,. G.W. Laver and G.B. Cox, 1994.  Structure and function of a novel ion channel.  In: Studies in honour of Karl Julius Ullrich: an Australian symposium, edited by Poronnik, P., Cook, D.I. and J.A. Glebe. NSW Sydney Australia:  Fast Books, Wild & Woolley Pty Ltd, p. 11-14.


N.A. Sunstrom, L.S. Premkumar, A. Premkumar, G.W. Laver, G.B. Cox, and P.W. Gage. 1994.  An influenza B virus protein, NB, forms ion channels. Proc. Aust. Physiol. Pharmacol. Soc. 25: 193p.

 

J.Bertin, N.A. Sunstrom, and N.H. Acheson. 1993. Mutation of large T-antigen binding site A, but not site B or C, eliminates stalling by RNA polymerase II in the intergenic region of polyomavirus DNA. J. Virol. 67:5766-5775.

 

J. Bertin, N.A. Sunstrom, P. Jain and N.H. Acheson. 1992.  Stalling by RNA Polymerase II in the Polyomavirus Intergenic Region Is Dependent on Functional Large T Antigen. Virology 189: 715-724.


N.A. Sunstrom,  N.H. Acheson , and J.A. Hassell. 1991. Definition of the Origin-specific DNA Binding Domain  of Polyomavirus Large T Antigen. J. Virol. 65: 6998-7007.

Back to Key People